This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Apr 10;104(7):829-31.

doi: 10.1161/CIRCRESAHA.109.196329.

Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling

Ryosuke Nishio, Akira Matsumori

PMID: 19359605
DOI: 10.1161/CIRCRESAHA.109.196329

Editorial

Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling

Ryosuke Nishio et al. Circ Res. 2009.

. 2009 Apr 10;104(7):829-31.

doi: 10.1161/CIRCRESAHA.109.196329.

Authors

Ryosuke Nishio, Akira Matsumori

PMID: 19359605
DOI: 10.1161/CIRCRESAHA.109.196329

No abstract available

PubMed Disclaimer

Comment on

Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH, Shi Y, Chen Y, Sun M, Sader S, Maekawa Y, Arab S, Dawood F, Chen M, De Couto G, Liu Y, Fukuoka M, Yang S, Da Shi M, Kirshenbaum LA, McCulloch CA, Liu P. Li GH, et al. Circ Res. 2009 Apr 10;104(7):896-904. doi: 10.1161/CIRCRESAHA.108.172882. Epub 2009 Feb 26. Circ Res. 2009. PMID: 19246681

Similar articles

Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH, Shi Y, Chen Y, Sun M, Sader S, Maekawa Y, Arab S, Dawood F, Chen M, De Couto G, Liu Y, Fukuoka M, Yang S, Da Shi M, Kirshenbaum LA, McCulloch CA, Liu P. Li GH, et al. Circ Res. 2009 Apr 10;104(7):896-904. doi: 10.1161/CIRCRESAHA.108.172882. Epub 2009 Feb 26. Circ Res. 2009. PMID: 19246681
Myocyte apoptosis in heart failure.
van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ. van Empel VP, et al. Cardiovasc Res. 2005 Jul 1;67(1):21-9. doi: 10.1016/j.cardiores.2005.04.012. Cardiovasc Res. 2005. PMID: 15896727 Review.
[Molecular and cellular mechanisms of myocardial remodeling in heart failure].
Kremneva LV, Abaturova OV. Kremneva LV, et al. Klin Med (Mosk). 2003;81(2):4-7. Klin Med (Mosk). 2003. PMID: 12685226 Review. Russian.
Interventional effect of valsartan on expression of inducible cAMP early repressor and phosphodiesterase 3A in rats after myocardial infarction.
Ma D, Fu L, Shen J, Zhou P, Gao Y, Xie R, Li Y, Han Y, Wang Y, Wang F. Ma D, et al. Eur J Pharmacol. 2009 Jan 14;602(2-3):348-54. doi: 10.1016/j.ejphar.2008.11.002. Epub 2008 Nov 9. Eur J Pharmacol. 2009. PMID: 19027736
Prevention of heart failure and postinfarction remodeling.
Deedwania PC. Deedwania PC. Cardiol Clin. 1994 Feb;12(1):155-64. Cardiol Clin. 1994. PMID: 8181022 Review.

See all similar articles

Cited by

Proteomics of acute heart failure in a rat post-myocardial infarction model.
Guo Y, Cui L, Jiang S, Zhang A, Jiang S. Guo Y, et al. Mol Med Rep. 2017 Aug;16(2):1946-1956. doi: 10.3892/mmr.2017.6820. Epub 2017 Jun 20. Mol Med Rep. 2017. PMID: 28656274 Free PMC article.
Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosis.
Alvarez-Llamas G, Martín-Rojas T, de la Cuesta F, Calvo E, Gil-Dones F, Dardé VM, Lopez-Almodovar LF, Padial LR, Lopez JA, Vivanco F, Barderas MG. Alvarez-Llamas G, et al. Mol Cell Proteomics. 2013 Sep;12(9):2426-39. doi: 10.1074/mcp.M113.027425. Epub 2013 May 23. Mol Cell Proteomics. 2013. PMID: 23704777 Free PMC article.
Gelsolin (GSN) induces cardiomyocyte hypertrophy and BNP expression via p38 signaling and GATA-4 transcriptional factor activation.
Hu WS, Ho TJ, Pai P, Chung LC, Kuo CH, Chang SH, Tsai FJ, Tsai CH, Jie YC, Liou YM, Huang CY. Hu WS, et al. Mol Cell Biochem. 2014 May;390(1-2):263-70. doi: 10.1007/s11010-014-1977-7. Epub 2014 Feb 7. Mol Cell Biochem. 2014. PMID: 24505034
PI3Kα-regulated gelsolin activity is a critical determinant of cardiac cytoskeletal remodeling and heart disease.
Patel VB, Zhabyeyev P, Chen X, Wang F, Paul M, Fan D, McLean BA, Basu R, Zhang P, Shah S, Dawson JF, Pyle WG, Hazra M, Kassiri Z, Hazra S, Vanhaesebroeck B, McCulloch CA, Oudit GY. Patel VB, et al. Nat Commun. 2018 Dec 19;9(1):5390. doi: 10.1038/s41467-018-07812-8. Nat Commun. 2018. PMID: 30568254 Free PMC article.
A llama-derived gelsolin single-domain antibody blocks gelsolin-G-actin interaction.
Van den Abbeele A, De Clercq S, De Ganck A, De Corte V, Van Loo B, Soror SH, Srinivasan V, Steyaert J, Vandekerckhove J, Gettemans J. Van den Abbeele A, et al. Cell Mol Life Sci. 2010 May;67(9):1519-35. doi: 10.1007/s00018-010-0266-1. Epub 2010 Feb 7. Cell Mol Life Sci. 2010. PMID: 20140750 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program